Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. Transcript, audio, 6-K call announcement stay in one workspace.
Earnings call · FY2026 Q3
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Executive readout · one minute
Read the call alongside every captured source. Transcript, audio, 6-K call announcement stay in one workspace.
Management tone
Positive
Net tone +20 · moderate hedging
Forward guidance
2 guided metrics
Management's latest ranges and targets are included below.
Research coverage
3 live sources
Switch sources without leaving this page or losing your listening position.
Open the source you need; every reader stays inside this workspace.
Stated verbally and extracted from the transcript.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Full year sales volume growth outlook
Initiated
full year
|
5% | — | |
|
CapEx
three years, 26 to 28
|
$3B | — |
Thank you for standing by. Welcome to SQM third quarter 2026 conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To participate, you will need to press star 1-1 on your telephone. You will then hear a message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. Now it's my pleasure to turn the call to Megan Suter with Investor Relations. Please proceed.
Good day, and thank you for joining FQM Group's Earning Conference Call for the third quarter of 2026. This call is being recorded and webcast live. Our earnings press release and the accompanying result presentations are available on our website, where you can also find a link to the webcast. Today's participants include Mr. Ricardo Ramos, Chief Executive Officer, Mr. Gerardo Allanez, Chief Financial Officer, Mr. Carlos Silla, CEO of the Novandino Division. Mr. Pablo Altimira, CEO of the FQM Division. Mr. Mark Fohn, CEO of the International Lithium Division. Also joining us today are members of our commercial and business intelligence team. Mr. Felipe Smith, Commercial Vice President of the Novandino Division. Mr. Pablo Hernandez, Vice President of Strategy and Development of the Novandino Division. Mr. Juan Pablo Velolio, Commercial Vice President for Plant Nutrition and Specialty Products, Mr. Alvaro Arraya, CFO of the International Lithium Division, Mr. Andres Fontanaz, Commercial Vice President of the International Lithium Division, and Mr. Max Vial, Head of Studies of the International Lithium Division. Before we begin, please note that statements made during this call regarding our business outlook, future economic performance, anticipated profitability, revenues, expenses, and other financial items, along with expected cost synergies and product or service line growth, are considered forward-looking statements under U.S. federal securities laws. These statements are not historical facts and are subject to risks and uncertainties that could cause actual results to differ materially. We assume no obligation to update these statements except as required by law. For a full discussion of forward-looking statements, please refer to our earnings press release and presentation. With that, I will now turn the call over to our Chief Executive Officer, Mr. Ricardo Ramos.
Thank you. Good morning, everyone, and thank you for joining us today. I'm pleased to present SKM Group's third quarter results. We continue to deliver solid performance across our main business lines with positive year-over-year results reporting close to $1.6 billion as net income during the first three quarters of the year, almost four times higher than the next income reported in the same period in 2025. Starting with lithium, we continue to see encouraging demand trends and remain extremely confident in the long-term growth prospects of the market. Although lithium market today, price today, is significantly lower since the peak observed during the second quarter, we continue to see healthy demand growth for lithium. Consequently, it's reasonable to expect prices should increase in the near future. Demand growth is being supported not only by electric vehicle adoption, but also by increasing lithium content in vehicles, as the expansion of markets beyond China and the growing contribution of battery energy storage system. We estimate that global lithium demand could grow by approximately 30% in 2026, and we expect the market could surpass 3 million metric tons by 2030. From an operational and commercial perspective, both lithium divisions perform in line with our expectations. Moving to iodine, we once again deliver solid performance results, supported by healthy market demand and favorable price conditions. Demand for iodine and its derivative continue to be driven primarily by X-ray contrast media. We expect global iodine demand to grow over 3% in both 2026 and 2027, supported by these applications. We remain focused on strengthening our position as a reliable supplier while advancing our operational efficiency and production capacities. Turning to specialty plant nutrition, this business also continued to demonstrate good commercial activity during the third quarter. We saw strong sales across our traditional markets. However, higher prices, fertilizer prices have resulted in lower customer demand, and as a result, we revised our full year sales volume growth outlook to approximately 5% over last year. Meanwhile, prices have continued to show a positive trend. Overall, we remain focused on delivering solid operating and commercial performance, maintaining our long-term perspective while preserving financial discipline. Thank you.
Ladies and gentlemen, as a reminder, if you do have a question, press star 11 on your telephone.
To remove yourself, press Star 1-1 again.
One moment for our first question, please. One minute. It comes from the line of Joel Jackson with BMO Capital Markets. Please proceed.
Hi, do you hear me? Hi, sorry. Do you hear me?
Yes. Yes, we can.
Sorry, a bit of a lag. I'm sorry. I'm sorry. Thanks for taking my questions. I'll ask them one by one. So we've seen a bit of turn on the lithium market, obviously, since the end of the summer, since the summer, and prices come down, a lot of concerns about 2027. I have a question I want to ask, which is, how much of the 30% lithium demand growth this year that you project that we're seeing, how much of that 30% has been demand, like end use consumption versus inventory building? And what do you think demand growth looks like in 27, based on all that you know?
Hey, Joe. This is Pablo Hernández speaking. So as Ricardo has said, we are very strong on the demand for this year and then the upcoming years. And out of the 30%, we believe most of that has been in customers, as we have seen and you have seen in the market, the inventory levels have dropped during this year. And regarding your question on 2027, we expect growth for the next year in the numbers of close to 2.5 million metric tons of demand, which would represent somewhere in the 15 to 20 percent growth.
Okay, and can you talk about what we're seeing in the market right now? We all see the inventory numbers, but we see the concerns of 2027. When you think about that 15 to 20% demand growth next year, I mean, how are you baking in some of the concerns on ESS we've seen, be it lower IRRs based on things going on in China, be it some penetration on sodium? How has your ESS view changed versus, say, six months ago?
Yep. So we still remain very strong on the demand for BSS. We expect a growth in the range of 15% for the upcoming year. So we remain very, very confident about the demand on the BSS side. And on your question on Sodomayen, Indeed, we've seen the development of this new technology. We strongly believe that lithium is very well positioned to continue to grow in this space. And sodium ion, of course, at some point might take some small spaces in the market, but lithium has some natural advantages in terms of cost, production cost, I mean, and energy density over sodium ion.
Okay, then my final question is sort of tying… Tying it together. So you see overall lifting demand growth up next year, 15% to 20%, and you see ESS demand growth as part of it up about 15% next year. That means you see EV demand also up around 15%, 15% to 20% next year, correct?
Yep, you're more or less in that same range, exactly.
Okay, thank you very much. Thank you very much.
Thank you. Our next question comes from Lucas Ferreira with JP Morgan.
Hi, guys. Thanks for the time. Also, on the fundamentals of the lithium market, wondering if you can comment on how do you see the lithium inventory situation on the ground in China, in different channels, in ports and in the upstream. So how these inventories have been changing over the last few months, if you still see a tight market or wondering how much of that lithium price decline we have been seeing is also influenced by the sentiment on the whole, let's say, downward revision of growth rates or if it's sustained by fundamentals as well, in your view. And on the SQM side, I'm wondering if there's any updates to your production expectations or sales expectations for this year, and wondering if you can also say something about the 27, how you're seeing production sales. Thank you very much.
Hey, Lucas. Paulo Hernández speaking. So on your lithium question, as you mentioned, indeed, during 2026, we have seen a very significant price fluctuation with prices, of course, below the numbers we've seen during mid of the year. But as Ricardo mentioned, we remain very strong on demand. We're very confident in the growth for the next coming years. Ricardo mentioned demand is expected to be over the 3 million metric tons by 2030. So that shows how much lithium will be required for just for the next few years. And additionally, of course, current demand is a more robust one, more robust than the one we had a few years ago. We now have two significant drivers, EVs and BSS. And not only that, we also have a more diverse demand from a global market perspective, which helps absorb, of course, specific market fluctuations. And finally, I would say it's important to also remember that the current price level seems to be... Sitting below the necessary incentive price required to bring new supply to fulfill this demand, and therefore, we should expect some price increase in the future.
Hello, this is Carlos Diaz speaking. I'm going to talk about the production for this year and next year from the Novandino division. For the third quarter, we reached a production close to 75,000. It was quite similar that we reached in the quarter two. And for this year, we expect to produce close to 290,000 metric tons, all coming from the Salon de la Cama. And for next year, we expect to continue to increase in our efficiency programs and to increase recovery and so on, and more initiative in order to reach production a little bit over 300,000.
Thank you very much, guys.
Thank you. Our next question comes from the line of Ben Isakson with Scotia Bank.
Thank you very much.
Can you hear me okay? A little far, if you can get closer to the microphone.
Okay, I'll talk louder. I have three questions. So first question is, if prices stay where they are right now, Geraldo, does the cadence or the timing of your CapEx spend, does that change? Do you start to delay that? And is the financing of that change as well?
Hi, Ben. Ricardo Ramos speaking. Our CAPEX, the one that we discussed, I think, last time we have a conference call, we remain the same. We don't foresee any reason to change our capital expenditure considering what is today in price environment. We are very, very positive about what's going on in the future, and our CAPEX is very full focus in what we think we have real competitive advantages.
Okay, thank you. And my next question is on lithium sulfate. What is the run rate that we should be using on a go-forward basis, and if the economics between your plant and tolling are similar, why do you need the plant? Why don't you just do tolling 100%?
So, regarding to the lithium sulfate production, this year we expect to produce 160,000, that is more or less equivalent to 80,000 as a lithium carbonate, and for next year we expect to increase a little bit that production. And, yes, we still have our own factory in China where we produce more than 20,000 as a lithium carbonate, and the remaining production is we do through dollars in China. Well, we always are evaluating to increase our capacity in China, in Chile, and there are some under evaluation always, but nothing has been decided yet.
Okay, and my last question is on SPN. Volumes went down, and you talked about farmers pushing back a little bit on higher prices. Can you just give some color and some detail? What specific products was it? Was it all NOP? And what were the regions that you saw this pushback in demand? And was it just because NOP prices were high following what China did earlier in the year? And do you expect it to normalize?
Excuse me, Ben, this is Juan Pablo. Could you please repeat the question, because we love the second part.
I'm sorry. The question is on SPN. What specifically were the regions and the products that caused lower volumes, and do you expect that demand to come back?
Okay, Ben. I would say, as you know, we sell in mostly all of the countries, more than 100 countries, so our sales are very diversified, and the impact of higher prices in different products has reached, I would say, all markets. It's not that we have one market specifically that... Rules, the decline on volumes. You need to remember also that we sold a huge volume in Q2. So if you consider the balance between Q2 and Q3, it's more or less the same volume than last year. Okay. So in terms of our sales, in total year, actually, well, it's still up compared to last year. So Q3 could be something exceptional, and we expect that Q4 would be more or less similar to what we saw last year. In terms of the higher prices and which products, of course, phosphates are the ones that are making the higher increase, affecting our sales of distribution in phosphate products, but also on the NPKs that use. Those products I would say are the ones with a higher impact. And that's why we have compensated this with higher sales on potassium nitrate, our main product. And in terms of the question about MOP, you need to remember that our potash business line consider MOP, but also SOP. The SOP price has gone up. During the year. So, and the proportion of SOP today is higher than in the past year. So, that's why you see that price increase.
Thank you very much.
Thank you. Our next question comes from the line of Corinne Blanchard with Deutsche Bank. Please proceed.
Hey, good morning, guys. Thank you for taking my question. Maybe I want to go back on the international lithium division for Mount Holland. Can you give a little bit more detail or clarity on the expectation for volume for 2027? Because I think based on your commentary so far, it seems like 4Q will be a nice step up versus the rest of the year. So just wondering if that's continuing to 20, 20, 27.
Hi, Corinne. This is Mark Fones here. Our guidance for this year in terms of production for the concentrator at Monholland continues to be in the same range of between 175,000 and 185,000 tons of sodium concentrate 6%. That's currently working at nameplate capacity or even slightly above nameplate capacity, and we expect the plant to continue working in that perspective for next year. The amount of direct sales out of that is still on question regarding our ramp-up nameplate, into nameplate for the refinery, and that's a plan that is currently being derived, and once we have a better view on that, we will inform you at your time.
Okay, and then maybe the second part, I'm sorry if it has been asked, but on the potash, do you guys are still expecting, like what the strategy there over 27, 20, 28, I think before you had mentioned, you know, you would not have any more, any potash volume due to the strategy for the lithium side, but can you just give like a better, maybe on the view of the timing and how do we think about those volume for next year in 28?
A moment for our next question, please.
It comes from Isabella Cibonacci, Bank of America.
I'm sorry, I know.
Please go ahead.
Corinne, this is Carlos Díaz of the Noramandino division. Well, in Noramandino, we are focused to produce lithium as a main product, and potash is like a second product or byproduct, and we mainly focus to produce for the production of the potassium nitrate, and when this some remind potash, the fertilizer division can sell in the market. So I'm going to say to Pablo if you can comment something about that.
Yes, I don't have too much to add, but what Carlos said is right. I mean, it's important to understand that we have a contract with Norandino that secures the availability of potage for our potassium nitrate business, which is the main business in agriculture business. And then, depending on the production, how is the production, and we have availability of potage to direct sales, we will continue with that because we have all the commercial offices to do it, our port, and so on. So, if we have availability, we will continue selling that product.
Thank you so much. Our next question comes from Isabella Simonato with Bank of America. Please proceed.
Thank you. Good afternoon, everyone. Thank you for the call and taking my question. I want to go back a little bit on the lithium side. I understand your constructive view about the market and demand growth, but more in the short term, and we are seeing prices coming down. I wonder if you have any sensitivity or... If we should see maybe prices accommodating at a lower level before they move up, or when do you expect us to see some sort of inflection point as the demand story continues to play out in 2027? Thank you.
Hello, Isabella. Paolo Hernández speaking. As I mentioned earlier, indeed, prices are considerably below what we've seen in the middle of the year, but of course, we remain very confident in the demand, and we don't know when the prices will increase, but we do expect, of course, a price increase in the near future.
Thank you. And just a follow-up on the potter's side, right? I guess we understand that you're structurally reducing potter's volumes, but can you give us a sense on maybe how much can we expect for the full year, 2027, in terms of potassium chloride volumes?
Hello, Isabella. This is Juan Pablo. We're still reviewing with our partners of Novandino our availability of commercial potash to place into the market. Of course, we believe that, as we have been commenting and saying in the past, that the volumes are going to go down. We don't know yet at what level, but you can consider that what we have been selling this year is going to be higher than next year.
Okay, thank you very much.
Thank you. Our last question comes from the line of Mateus Moreira with Bradesco PPI.
Thank you. Good morning, and thanks for taking my questions. A couple of questions on my side. First, on the CapEx, I mean, disbursements have been relatively light over the past few quarters, you know, year-to-date CapEx below $500 million. I'm just wondering what's the explanation for this lower-than-expected CapEx, if maybe the company is adjusting its expenditures to reflect these tougher conditions, and how should we expect CapEx moving in the next few quarters? That's my first question. Then the second question on lithium, I mean, costs were the negative surprise here against our numbers in the quarter. You know, with production pretty much aligned with our numbers, we would expect a slightly better cost performance. Could you help us understand what, I mean, the main drivers behind the cost performance in the third quarter, and what should we expect And then if I can squeeze in a last question on your mix, especially in the international division, I mean, you have the expansion in Mount Holland in the next couple of years. You're also ramping up the refinery in China. I'm just wondering what would be the ideal mix between sputumine and hydroxide in the next couple of years in the international division. Those are my questions.
Hi, Mateo. This is Gerardo speaking. Well, regarding your CapEx question, it's true. During the first three quarters of this year, CapEx was a little bit less than $500 million. What we informed last quarter is that we expect CapEx for three years, 26 to 28. To be in the neighborhood of $3 billion. On average, of course, that's $1 billion per year. During 2026, it's going to be slightly lower than that. But the projects are moving ahead based on the schedule that each of these projects have. And we have no, no, I mean, we have not made any changes to the CapEx plan so far.
So, coming about the lithium cost of the Novandino division,
I can say that we have been able to maintain our very competitive cost position, reducing our cost compared to the last year. And the cost of the third quarter is quite similar to what it was in the second quarter, and we expect the same almost cost during the fourth quarter. And indeed, the next year is going to be again at the same level, so we don't expect an increase in the cost, in spite of the inflation and the energy cost, because we have been able to reduce and to increase our productivity in order to keep our cost reduction in line. And again, it's going to be lower compared with last year.
Great, that's all clear. Thank you, Herardo.
Mateos, on the International Lithium Division. Our costs have remained stable in the last quarters. Our business is well positioned in this market context. As I mentioned before, the mine and concentrator is running at full capacity, with competitive costs in line with the Western Australian top producers. And the expansion will also provide us further lowering of unit costs into the future. I understand there was another question from your side, but we couldn't hear very well, if you want to follow up.
No, no, the final question was regarding the mix in the international division between spottamine and hydroxide. With Matt Holland ramping up, I mean, with Matt Holland expansion in the next few years and the Chinese refinery ramping up, how do you see the mix evolving between spottamine and hydroxide sales?
Yes, as I mentioned before, we are committed into the lithium hydroxide ramp up. The ramp up is progressing well. We have already very good product quality in terms of battery grade, which is increasing on a monthly basis. The exact amount of that distribution, which will be either consumed by the Quinana refinery or direct sales of sodium concentrate, as I mentioned earlier, that's something that still remains as matters of planning and budgeting season for covalent, and we will inform that duly once we have a better idea for next year.
Thank you. Okay, that's clear. Thank you.
Thank you so much, and ladies and gentlemen, this will conclude our Q&A session and conference for today. We thank you for participating, and you may now disconnect.
6:12 to 29:19 · One card per analyst, follow-ups included. Each plays from its start, and the one being answered is marked.
Hi, do you hear me? Hi, sorry. Do you hear me?
Pablo Hernandez: Hey, Joe. This is Pablo Hernández speaking. So as Ricardo has said, we are very strong on the demand for this year and then the upcoming years. And out of the 30%, we believe most of that has been in customers, as we have seen and you have seen in the market…
Hi, guys. Thanks for the time. Also, on the fundamentals of the lithium market, wondering if you can comment on how do you see the lithium inventory situation on the ground in China, in different channels, in ports and in the upstream. So how these inventories have been changing over the last few months, if you still…
Pablo Hernandez: Hey, Lucas. Paulo Hernández speaking. So on your lithium question, as you mentioned, indeed, during 2026, we have seen a very significant price fluctuation with prices, of course, below the numbers we've seen during mid of the year. But as Ricardo mentioned…
Also speaking: Carlos Diaz
Thank you very much.
Ricardo Ramos: Hi, Ben. Ricardo Ramos speaking. Our CAPEX, the one that we discussed, I think, last time we have a conference call, we remain the same. We don't foresee any reason to change our capital expenditure considering what is today in price environment. We are very…
Also speaking: Carlos Diaz, Juan Pablo Bellolio
Hey, good morning, guys. Thank you for taking my question. Maybe I want to go back on the international lithium division for Mount Holland. Can you give a little bit more detail or clarity on the expectation for volume for 2027? Because I think based on your commentary so far, it seems like 4Q will be a nice step up…
Mark Fones: Hi, Corinne. This is Mark Fones here. Our guidance for this year in terms of production for the concentrator at Monholland continues to be in the same range of between 175,000 and 185,000 tons of sodium concentrate 6%. That's currently working at nameplate…
I'm sorry, I know.
Carlos Diaz: Corinne, this is Carlos Díaz of the Noramandino division. Well, in Noramandino, we are focused to produce lithium as a main product, and potash is like a second product or byproduct, and we mainly focus to produce for the production of the potassium nitrate…
Also speaking: Pablo Altimiras
Thank you. Good afternoon, everyone. Thank you for the call and taking my question. I want to go back a little bit on the lithium side. I understand your constructive view about the market and demand growth, but more in the short term, and we are seeing prices coming down. I wonder if you have any sensitivity or... If…
Pablo Hernandez: Hello, Isabella. Paolo Hernández speaking. As I mentioned earlier, indeed, prices are considerably below what we've seen in the middle of the year, but of course, we remain very confident in the demand, and we don't know when the prices will increase, but we…
Also speaking: Juan Pablo Bellolio
Thank you. Good morning, and thanks for taking my questions. A couple of questions on my side. First, on the CapEx, I mean, disbursements have been relatively light over the past few quarters, you know, year-to-date CapEx below $500 million. I'm just wondering what's the explanation for this lower-than-expected CapEx…
Gerardo Illanes: Hi, Mateo. This is Gerardo speaking. Well, regarding your CapEx question, it's true. During the first three quarters of this year, CapEx was a little bit less than $500 million. What we informed last quarter is that we expect CapEx for three years, 26 to 28.…
So, coming about the lithium cost of the Novandino division,
Carlos Diaz: I can say that we have been able to maintain our very competitive cost position, reducing our cost compared to the last year. And the cost of the third quarter is quite similar to what it was in the second quarter, and we expect the same almost cost during the…
Great, that's all clear. Thank you, Herardo.
Mark Fones: Mateos, on the International Lithium Division. Our costs have remained stable in the last quarters. Our business is well positioned in this market context. As I mentioned before, the mine and concentrator is running at full capacity, with competitive costs in…
SEC call announcement
Filed Nov 18, 2026 · complete as-filed document